Concepedia

Vadim Romanov

VR

Statistics

Publications

5

Citations

229

H-Index

5

Active since

2005

Affiliations

University of Pennsylvania(Current)

UPMC Hillman Cancer Center

Oregon Health & Science University

Fred Hutch Cancer Center

Analysis Group (United States)

Vadim Romanov is an author at University of Pennsylvania specializing in oncology, immunotherapy, and relapsed diffuse large b-cell lymphoma.

Publications per year

2005–2020

5

Publications

5

Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion

Michael Bishop, Richard T. Maziarz, Edmund K. Waller et al. · Blood Advances · 2019 · 86 citations · Full text

, , +12

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

Stephen J. Schuster, Richard T. Maziarz, Elisha S. Rusch et al. · Blood Advances · 2020 · 76 citations · Full text

, , +16

Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

Richard T. Maziarz, Stephen J. Schuster, Vadim Romanov et al. · Blood Advances · 2020 · 44 citations · Full text

, , +17

CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY BY BASELINE TUMOR BURDEN IN ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL

Richard T. Maziarz, Stephen J. Schuster, Solveig G. Ericson et al. · Hematological Oncology · 2019 · 12 citations

, , +17

Basic fibroblast growth factor suppresses p53 activation in the neoplastic cells of a proportion of patients with chronic lymphocytic leukaemia

Vadim Romanov, Christine H James, Paul D. Sherrington et al. · Oncogene · 2005 · 11 citations

, , +16

1–5 of 5